CryoPort (CYRX) Stock Price, News & Analysis

Company Overview

Cryoport, Inc. (NASDAQ: CYRX) is a global provider of cryogenic logistics solutions for the life sciences industry. The company specializes in the temperature-controlled transportation and storage of biologic materials, including cell and gene therapies, vaccines, blood products and other temperature-sensitive compounds. Cryoport’s offerings span from dry vapor shippers and temperature monitoring devices to comprehensive shipment management services designed to safeguard the integrity of critical research and therapeutic shipments.

Core to Cryoport’s business is its Cryoport Express® service, a turnkey solution that integrates specialized shipping containers, real-time temperature tracking, data analytics and regulatory expertise. This platform supports preclinical and clinical trial phases, enabling pharmaceutical and biotech clients to move samples and therapies across international borders with confidence. In addition, Cryoport provides storage services, on-site temperature management and tailored logistics consulting to optimize clients’ cold-chain workflows.

Originally founded in 2010 as BioStorage Technologies, the company rebranded to Cryoport in 2014 to reflect its broader cold chain logistics focus. Over the years, Cryoport has expanded its portfolio through strategic partnerships, technology innovations and targeted acquisitions, reinforcing its position in the growing cell and gene therapy market. The company’s solutions have been used in thousands of clinical trials and commercial launches worldwide.

Cryoport operates from headquarters in Irvine, California, with regional hubs in Europe, Asia and Latin America to support 24/7 logistics. Under the leadership of President and CEO Tim O’Malley, the executive team emphasizes continuous process improvement and regulatory compliance to meet evolving global standards. Cryoport’s global infrastructure and specialized workforce aim to deliver reliable, end-to-end cryogenic logistics for customers pushing the frontiers of medical science.

Key Stats

• Today's Range: $7.42 to $7.52
• 50-Day Range: $5.40 to $7.64
• 52-Week Range: $4.58 to $9.78
• Volume: 193,889 shs
• Average Volume: 480,698 shs
• Market Capitalization: $372.69 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $10.88
• Consensus Rating: Moderate Buy

CryoPort Stock Analysis - MarketRank™

CryoPort scored higher than 32% of companies evaluated by MarketBeat, and ranked 92nd out of 125 stocks in the transportation sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.4 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

CryoPort has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on 6 buy ratings, 2 hold ratings, and no sell ratings.

Amount of Analyst Coverage

CryoPort has only been the subject of 3 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: Decreasing

Earnings Growth

Earnings for CryoPort are expected to decrease in the coming year, from ($0.99) to ($1.06) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of CryoPort is -3.19, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of CryoPort is -3.19, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

CryoPort has a P/B Ratio of 1.00. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

5.75% of the float of CryoPort has been sold short.

Short Interest Ratio / Days to Cover

CryoPort has a short interest ratio ("days to cover") of 5.6.

Change versus previous month

Short interest in CryoPort has recently increased by 13.11%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

CryoPort does not currently pay a dividend.

Dividend Growth

CryoPort does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

5.75% of the float of CryoPort has been sold short.

Short Interest Ratio / Days to Cover

CryoPort has a short interest ratio ("days to cover") of 5.6.

Change versus previous month

Short interest in CryoPort has recently increased by 13.11%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 1.6 / 5
• News Sentiment: 0.82

News Sentiment

CryoPort has a news sentiment score of 0.82. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Transportation companies.

News Coverage This Week

MarketBeat has tracked 3 news articles for CryoPort this week, compared to 3 articles on an average week.

MarketBeat Follows

Only 1 people have added CryoPort to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 2.5 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, CryoPort insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $3,042,327.00 in company stock.

Percentage Held by Insiders

Only 10.00% of the stock of CryoPort is held by insiders.

Percentage Held by Institutions

92.90% of the stock of CryoPort is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

CYRX Stock Analysis - Frequently Asked Questions

How have CYRX shares performed this year?

CryoPort's stock was trading at $7.78 at the beginning of the year. Since then, CYRX stock has decreased by 4.2% and is now trading at $7.4550.

How were CryoPort's earnings last quarter?

CryoPort, Inc. (NASDAQ:CYRX) released its earnings results on Wednesday, May, 7th. The company reported ($0.22) EPS for the quarter, topping analysts' consensus estimates of ($0.23) by $0.01. The firm earned $41.04 million during the quarter, compared to analysts' expectations of $56.19 million. CryoPort had a negative net margin of 50.15% and a negative trailing twelve-month return on equity of 11.03%.
Read the conference call transcript.

Is CryoPort doing a stock buyback?

CryoPort's Board of Directors initiated a share repurchase plan on Tuesday, August 6th 2024, which permits the company to repurchase $200,000,000 in outstanding shares, according to EventVestor. This means that the company could reacquire up to 49.1% of its shares through open market purchases. Shares buyback plans are usually an indication that the company's board believes its shares are undervalued.

Who are CryoPort's major shareholders?

CryoPort's top institutional investors include Assenagon Asset Management S.A. (2.17%), Wealth Enhancement Advisory Services LLC (0.03%) and Avanza Fonder AB (0.02%). Insiders that own company stock include Jerrell Shelton, Robert Stefanovich, Richard J Berman, Edward J Zecchini, Mark W Sawicki, Ramkumar Mandalam and Robert J Hariri.
View institutional ownership trends.

How do I buy shares of CryoPort?

Shares of CYRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of CryoPort own?

Based on aggregate information from My MarketBeat watchlists, some other companies that CryoPort investors own include American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), AU Optronics (AUOTY), DiamondRock Hospitality (DRH) and Humana (HUM).

Company Calendar

• Last Earnings: 5/07/2025
• Today: 7/17/2025
• Next Earnings (Estimated): 8/05/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Transportation
• Industry: TRANS - SERVICES
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:CYRX
• CIK: 1124524
• Web: www.cryoport.com
• Phone: (949) 470-2300
• Fax: 949-470-2306
• Employees: 1,186
• Year Founded: N/A

Price Target and Rating

• Average Price Target for CryoPort: $10.88
• High Price Target: $15.00
• Low Price Target: $7.00
• Potential Upside/Downside: +45.4%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.75
• Research Coverage: 8 Analysts

Profitability

• EPS (Trailing Twelve Months): ($2.34)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$114.76 million
• Net Margins: -50.15%
• Pretax Margin: -49.97%
• Return on Equity: -11.03%
• Return on Assets: -5.54%

Debt

• Debt-to-Equity Ratio: 0.51
• Current Ratio: 5.56
• Quick Ratio: 5.24

Sales & Book Value

• Annual Sales: $228.38 million
• Price / Sales: 1.64
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $7.44 per share
• Price / Book: 1.01

Miscellaneous

• Outstanding Shares: 50,140,000
• Free Float: 45,123,000
• Market Cap: $375.05 million
• Optionable: Optionable
• Beta: 1.89